Purpose: Evaluate the diagnostic potential of [F]FDG-PET/MRI data compared with invasive acquired biomarkers in newly diagnosed early breast cancer (BC).
Methods: Altogether 169 women with newly diagnosed BC were included. All underwent a breast- and whole-body [F]FDG-PET/MRI for initial staging.